Clinical Trial Update: Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years [NA]

View source ↗

Summary

A clinical trial evaluating adding montelukast to standard therapy for acute asthma in children aged 6-14 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Asthma | NA | Status: TERMINATED